13,139 resources
Start Prev Rows 9200 - 9400 Next
| Package | Version | Identity | Name/Title | Status | FMM | WG | Date | Auth | Source(s) |
|---|---|---|---|---|---|---|---|---|---|
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.304 | Pesticide Related Illness (Disorders) (SNOMED) | active | 2023-01 | hl7 | sct | ||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7807 | Bird Exposure Setting (RIBD) | active | 2018-01 | oid | |||
| fhir.r4.wales.test | R4 | DataStandardsWales-Sex | Data Standards Wales Sex | active | 2023-11 | hl7 | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7634 | Sexual Contact (FDD) | active | 2017-01 | tho | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3231 | Disease Type (STD) | active | 2009-01 | sct | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7639 | Shellfish Distributed (FDD) | active | 2017-01 | tho oid | |||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1235.619 | b.well Herpes Zoster Vaccine CN_HD_SNOMED | active | 2025-03 | hl7 | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1034.561 | Oral Steroid for Cluster Headache | active | 2023-12 | hl7 | rx | ||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7965 | Sick Animal Type (Leptospirosis) | active | 2020-01 | sct tho | |||
| fhir.cdc.opioid-cds-r4 | R4 | sickle-cell-diseases | Sickle-cell diseases | active | 2023-05 | hl7 | sct icd | ||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7771 | Side Effect Time to Onset (TB) | active | 2017-12 | oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7772 | Side Effect of Treatment (TB) | active | 2018-01 | sct tho oid | |||
| signal.core.r4 | R4 | signal-organization-license | Signal Organization License | draft | 2023-07 | hl7 | |||
| signal.core.r4 | R4 | signal-organization-qualification | Signal Organization Qualification | draft | 1 | pa | hl7 | ||
| signal.core.r4 | R4 | signal-healthcare-service-type | Signal Healthcare Service Type | draft | 1 | pa | hl7 | ||
| signal.core.r4 | R4 | signal-region | Signal Region | draft | hl7 | ||||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7662 | Signs and Symptoms (Measles) | active | 2018-01 | sct tho | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7283 | Signs and Symptoms (Mumps) | active | 2015-01 | sct tho | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7284 | Signs and Symptoms (Pertussis) | active | 2017-01 | sct tho | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3240 | Flu Signs and Symptoms | active | 2009-01 | sct | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7460 | Signs Symptoms (Arbovirus) | active | 2016-01 | sct oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7482 | Signs Symptoms (Chikungunya) | active | 2016-01 | sct | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7481 | Signs Symptoms (Dengue) | active | 2016-01 | sct | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7459 | Signs Symptoms (Zika) | active | 2016-01 | sct | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7225 | Signs Symptoms (CS) | active | 2020-01 | sct tho oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7723 | Signs and Symptoms (RIBD) | active | 2018-01 | sct tho | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7666 | Signs and Symptoms (Trich) | active | 2018-01 | sct tho | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7944 | Signs and Symptoms (COVID-19) | active | 2021-01 | sct tho | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.8059 | Signs and Symptoms (Hepatitis) | active | 2021-01 | sct oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7649 | Signs and Symptoms (Rubella) | active | 2018-01 | sct tho | |||
| hl7.fhir.us.directory-query | R4 | NetworkTypeVS | Network Type Value Set | active | 2022-12 | hl7 | fhir | ||
| hl7.fhir.us.davinci-pdex-plan-net | R4 | NetworkTypeVS | Network Type VS | trial-use | fm | 2025-02 | hl7 | fhir | |
| hl7.fhir.us.ndh | R4 | NetworkTypeVS | Network Type Value Set | trial-use | pa | 2025-07 | hl7 | tho | |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7778 | Specimen Site (FDD) | active | 2018-01 | sct tho oid | |||
| signal.core.r4 | R4 | procedure-not-performed-reason | Procedure Not Performed Reason (SNOMED-CT) | draft | 1 | pc | 2019-10 | hl7 | sct |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.8022 | Skin Smear Interpretation (Hansen) | active | 2020-01 | oid | |||
| fhir.argonaut.scheduling | R3 | slot-bundle-type | Argonaut Slot BundleType Codes | active | 2017-01 | hl7 | fhir | ||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.6027 | Smoking Status (PI) | active | 2019-01 | sct | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3228 | Sociobehavioral risk factor | active | 2009-01 | sct loinc | |||
| hl7.fhir.us.davinci-pdex | R4 | ProvenancePayerSourceFormat | Payer source of data | informative | fm | 2025-06 | hl7 | fhir | |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3148 | PCR Specimen Source (VZ) | active | 2017-01 | sct tho oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7655 | PCR Specimen Source (CRS) | active | 2017-01 | sct tho oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3088 | Information Source | active | 2008-01 | sct tho | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3128 | Immunization Information Source (CRS) | active | 2008-01 | sct tho oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.8055 | Source of Laboratory Test (Hepatitis) | active | 2021-01 | sct tho oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3082 | Fetal Neonatal Specimen Type | active | 2008-01 | sct tho | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7800 | Respondent (Listeria) | active | 2018-01 | tho oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3105 | Tap Water Source (FDD) | active | 2008-01 | tho oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.8038 | Specimen Source Site (Brucellosis) | active | 2021-01 | sct tho oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7943 | Data Reporting Source (COVID-19) | active | 2020-01 | tho oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.990 | Specimen Handling Code | active | 2008-01 | tho | |||
| hl7.fhir.us.directory-query | R4 | SpecialtyAndDegreeLicenseCertificateVS | Specialties, Degrees, Licenses, and Certificates Value Set | active | 2022-12 | hl7 | fhir tho | ||
| hl7.fhir.us.davinci-pdex-plan-net | R4 | SpecialtyAndDegreeLicenseCertificateVS | Specialties, Degrees, Licenses, and Certificates VS | trial-use | fm | 2025-02 | hl7 | fhir tho | |
| hl7.fhir.us.ndh | R4 | SpecialtyAndDegreeLicenseCertificateVS | Specialties, Degrees, Licenses, and Certificates Value Set | trial-use | pa | 2025-07 | hl7 | vsac tho | |
| hl7.fhir.us.directory-query | R4 | SpecialtiesVS | Specialties Value Set | active | 2022-12 | hl7 | fhir | ||
| hl7.fhir.us.davinci-pdex-plan-net | R4 | SpecialtiesVS | Specialties VS | trial-use | fm | 2025-02 | hl7 | fhir nucc | |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7836 | Organism (TBRD) | active | 2018-01 | sct tho oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.8010 | Organism Name (Brucellosis) | active | 2020-01 | sct tho | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3313 | Species (Malaria) | active | 2010-01 | sct tho | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3066 | Bat Species (Animal Rabies) | active | 2008-01 | sct tho | |||
| hl7.fhir.us.registry-protocols | R4 | VentricularSupportDeviceType | Ventricular Support Device Type | active | cic | 2023-11 | hl7 | fhir sct | |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.876 | Detailed Race | active | 2008-01 | oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.823 | Referral Reason (HL7) | active | 2008-01 | tho | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3023 | Immunization Body Site | active | 2008-01 | tho oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7697 | Birth Location (RIBD) | active | 2018-01 | sct tho oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3040 | Isolate Not Available EIP Test Reason | active | 2008-01 | tho oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3042 | Isolate Not Sent To NARMS Reason | active | 2008-01 | tho oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3041 | Isolate Not Received Reason | active | 2008-01 | tho oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3080 | Eosin Units (FDD) | active | 2008-01 | ucum sct | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7837 | Coinfection Type (TBRD) | active | 2018-01 | sct tho | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7668 | Meat Consumed Type (Trich) | active | 2018-01 | tho oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3282 | Specimen Collection Method | active | 2010-01 | sct | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3020 | Specimen Source (PHLIP) | active | 2008-01 | tho | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.6046 | Specimen Type (HL7) | active | 2012-01 | tho | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.946 | Specimen | active | 2019-12 | sct | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7921 | Specimen type (ARLN) | active | 2019-01 | sct tho oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7627 | Specimen Collection Source (FDD) | active | 2018-01 | sct tho oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7802 | Specimen Type (Listeria) | active | 2018-01 | sct tho oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7616 | Specimen From Mother Or Infant (CRS) | active | 2017-01 | sct tho | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3141 | Specimen Source (VPD) | active | 2008-01 | sct tho | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7656 | Specimen Source (Rubella) | active | 2017-01 | sct tho | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7813 | Specimen Source (CP-CRE) | active | 2018-01 | sct tho | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.3.20 | Specimen Source Site (Anthrax) | active | 2020-01 | sct tho | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3140 | Specimen Source (CRS) | active | 2008-01 | sct tho oid | |||
| hl7.fhir.us.mcode | R4 | mcode-human-specimen-type-vs | Human Specimen Type Value Set | active | 1 | cic | 2025-02 | hl7 | tho |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.1047 | Specimen Treatment | active | 2008-01 | tho | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7774 | Specimen Type (RIBD) | active | 2019-01 | sct tho oid | |||
| hl7.fhir.us.mcode | R4 | mcode-clin-or-path-modifier-vs | Clinical or Pathologic Modifier | active | cic | 2025-02 | hl7 | sct | |
| hl7.fhir.us.mcode | R4 | mcode-lymphoma-stage-value-vs | Lymphoma Stage Value Set | active | cic | 2025-02 | hl7 | ncit sct | |
| hl7.fhir.us.mcode | R4 | mcode-lymphoma-staging-method-vs | Lymphoma Staging System Value Set | active | cic | 2025-02 | hl7 | ncit sct | |
| hl7.fhir.us.mcode | R4 | mcode-tnm-staging-method-vs | TNM Staging Method Value Set | active | cic | 2025-02 | hl7 | ncit sct | |
| hl7.fhir.us.mcode | R4 | mcode-figo-staging-method-vs | FIGO Staging Method Value Set | active | cic | 2025-02 | hl7 | sct | |
| hl7.fhir.us.mcode | R4 | mcode-lymphoma-stage-value-modifier-vs | Lymphoma Stage Value Modifier Value Set | active | cic | 2025-02 | hl7 | sct | |
| hl7.fhir.us.mcode | R4 | mcode-cancer-staging-method-vs | Cancer Staging Method Value Set | active | 4 | cic | 2025-02 | hl7 | ncit sct |
| hl7.fhir.us.breastcancer | R3 | oncology-StainingIntensityVS | BC StainingIntensityVS ValueSet | draft | 2018-08 | hl7 | sct | ||
| us.cdc.phinvads | R4 | 2.16.840.1.113883.3.2074.1.1.2 | Pt Immunization Registry Status Excluding Nulls | active | 2012-01 | tho | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.830 | State | active | 2008-01 | oid | |||
| fhir.outburn.co.il | R4 | vs-condition-clinical-status | Condition Clinical Status | draft | hl7 | tho | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7829 | Series Status (IIS) | active | 2018-01 | loinc | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.1036 | Referral Status (CRA) | active | 2008-01 | sct tho | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7231 | Result Status (NND) | active | 2020-01 | tho | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3600 | Stay Period Hepatitis (NETSS) | active | 2011-01 | tho oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3321 | Sterile Specimen (IPD) | active | 2010-01 | sct tho | |||
| us.cdc.phinvads | R4 | 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.38 | Glucocortico Steroids (NCHS) | active | 2014-01 | rx | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7812 | Case Type (CP-CRE) | active | 2018-01 | tho oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7752 | Strength of Link (TB) | active | 2017-12 | sct | |||
| hl7.fhir.us.registry-protocols | R4 | StressTestResults | Stress Test Results | active | cic | 2023-11 | hl7 | fhir | |
| hl7.fhir.us.registry-protocols | R4 | StressTestRiskExtentofIschemia | Stress Test Risk/Extent of Ischemia | active | cic | 2023-11 | hl7 | fhir | |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7536 | Height Unit (CDC) | active | 2016-01 | ucum | |||
| hl7.fhir.us.registry-protocols | R4 | SubmissionType | Submission Type | active | cic | 2023-11 | hl7 | fhir | |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3597 | Identifier Type (Syndromic Surveillance) | active | 2011-01 | tho | |||
| hl7.fhir.us.pacio-pfe | R4 | pfe-us-core-category-vs | Personal Functioning and Engagement US Core Value Set | trial-use | 3 | pc | 2025-07 | hl7 | fhir |
| hl7.fhir.us.pq-cmc-fda | R5 | substance-classification | Substance Classification | trial-use | 2 | brr | 2025-07 | hl7 | ncit |
| hl7.fhir.us.registry-protocols | R4 | SurgicalRisk | SurgicalRisk | active | cic | 2023-11 | hl7 | fhir | |
| hl7.fhir.us.ccda | R4 | 2.16.840.1.113883.11.20.1.1 | SurgicalOperationNoteDocumentTypeCode | trial-use | cgp | 2018-05 | hl7 | loinc | |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7761 | Susceptibility Test Interpretation (TB) | active | 2018-01 | sct tho | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7762 | Susceptibility Test Method (TB) | active | 2017-12 | sct tho | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7760 | Susceptibility Test Type (TB) | active | 2022-01 | oid loinc | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3336 | Susceptibility Result (IPD) | draft | sct tho oid | ||||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3103 | Suspected Food Consumed (FDD) | active | 2008-01 | tho oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3104 | Swimming Pool Type (FDD) | active | 2008-01 | tho oid | |||
| hl7.fhir.us.registry-protocols | R4 | SyntaxScore | Syntax Score for the PCI procedure | active | cic | 2023-11 | hl7 | fhir | |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7229 | Syphilis Treatment Infant (CS) | active | 2020-01 | sct tho oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7221 | Syphilis Treatment Mother (CS) | active | 2020-01 | tho oid | |||
| hl7.fhir.us.vrdr | R4 | vrdr-system-reject-vs | System Reject ValueSet | active | pher | 2024-10 | hl7 | fhir | |
| us.nlm.vsac | R4 | 1.3.6.1.4.1.6997.4.1.2.265.15.31305.1.11.2.999.193 | Conditions Associated with Head and Neck Radiotherapy | active | 2017-03 | hl7 | icd | ||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3156 | Reporting Area (TB) | active | 2008-01 | oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.995 | Health Care Practice Type (TB) | active | 2008-01 | sct tho oid | |||
| fhir.outburn.co.il | R4 | vs-loinc-tbd | TBD LOINC Codes | draft | hl7 | ||||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7512 | City Places (NCHS) | active | 2017-01 | oid | |||
| hl7.fhir.us.registry-protocols | R4 | TIMIFlow | TIMI Flow | active | cic | 2023-11 | hl7 | sct | |
| fhir.r4.nhsengland.programme | R4 | England-TaskCode | England Task Code | draft | 2024-10 | hl7 | fhir sct | ||
| fhir.r4.nhsengland.programme | R4 | England-JobRoleCode | England Job Role Code | draft | 2024-10 | hl7 | tho | ||
| hl7.fhir.us.pco | R4 | prom-target-measures | PROM Target Measure Scores | draft | 2 | pc | 2025-08 | hl7 | loinc |
| hl7.fhir.us.codex-radiation-therapy | R4 | codexrt-radiotherapy-free-breathing-motion-mgmt-technique-vs | Radiotherapy Free-Breathing Motion Management Technique Value Set | active | cgp | 2025-02 | hl7 | sct | |
| signal.core.r4 | R4 | contact-point-system | ContactPointSystem | draft | 0 | fhir | 2019-10 | hl7 | fhir |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7790 | Heated Food (Listeria) | active | 2018-01 | tho oid | |||
| hl7.fhir.us.vitals | R4 | MeasurementProtocolVS | Measurement Protocol value set | draft | 2024-10 | hl7 | fhir | ||
| hl7.fhir.us.cardx-htn | R4 | MeasurementProtocolVS | Measurement Protocol value set | draft | 2023-08 | hl7 | fhir | ||
| hl7.fhir.us.pco | R4 | goal-barrier-codes | Goal Barrier Assessment Codes | draft | 2 | pc | 2025-08 | hl7 | sct |
| hl7.fhir.us.pco | R4 | readiness-assessment-codes | Readiness Assessment Codes | draft | 2 | pc | 2025-08 | hl7 | fhir |
| hl7.fhir.us.pq-cmc-fda | R5 | spl-pharmaceutical-dosage-form-terminology | Pharmaceutical Dosage Form Terminology | trial-use | 2 | brr | 2025-07 | hl7 | ncit |
| hl7.fhir.us.pq-cmc-fda | R5 | spl-drug-route-of-administration-terminology | Drug Route Of Administration Terminology | trial-use | 2 | brr | 2025-07 | hl7 | ncit |
| hl7.fhir.us.pq-cmc-fda | R5 | pqcmc-name-part-terminology | PQCMC Name Part Terminology | trial-use | 2 | brr | 2025-07 | hl7 | tho |
| hl7.fhir.us.pq-cmc-fda | R5 | pqcmc-batch-utilization-terminology | Batch utilization Terminology | trial-use | 2 | brr | 2025-07 | hl7 | ncit |
| hl7.fhir.us.pq-cmc-fda | R5 | pqcmc-chemical-structure-datafile-type-terminology | Chemical Structure Data File Type Terminology | trial-use | 2 | brr | 2025-07 | hl7 | ncit |
| hl7.fhir.us.pq-cmc-fda | R5 | pqcmc-closure-type-terminology | Closure Type Terminology | trial-use | 2 | brr | 2025-07 | hl7 | ncit |
| hl7.fhir.us.pq-cmc-fda | R5 | pqcmc-container-type-terminology | Container Type Terminology | trial-use | 2 | brr | 2025-07 | hl7 | ncit |
| hl7.fhir.us.pq-cmc-fda | R5 | pqcmc-drug-product-component-function-category-terminology | Drug Product Component Function Category Terminology | trial-use | 2 | brr | 2025-07 | hl7 | ncit |
| hl7.fhir.us.pq-cmc-fda | R5 | pqcmc-excipient-function-terminology | Excipient Function Terminology | trial-use | 2 | brr | 2025-07 | hl7 | ncit |
| hl7.fhir.us.pq-cmc-fda | R5 | pqcmc-impurity-classification-terminology | Impurity Classification Terminology | trial-use | 2 | brr | 2025-07 | hl7 | ncit |
| hl7.fhir.us.pq-cmc-fda | R5 | pqcmc-quality-benchmark-terminology | Quality Benchmark Terminology | trial-use | 2 | brr | 2025-07 | hl7 | ncit |
| hl7.fhir.us.pq-cmc-fda | R5 | pqcmc-source-type-terminology | Source Type Terminology | trial-use | 2 | brr | 2025-07 | hl7 | ncit |
| hl7.fhir.us.pq-cmc-fda | R5 | pqcmc-specification-status-terminology | Specification Status Terminology | trial-use | 2 | brr | 2025-07 | hl7 | ncit |
| hl7.fhir.us.pq-cmc-fda | R5 | pqcmc-specification-type-terminology | Specification Type Terminology | trial-use | 2 | brr | 2025-07 | hl7 | ncit |
| hl7.fhir.us.pq-cmc-fda | R5 | pqcmc-strength-type-terminology | Strength Type Terminology | trial-use | 2 | brr | 2025-07 | hl7 | ncit |
| hl7.fhir.us.pq-cmc-fda | R5 | pqcmc-test-category-terminology | Test Category Terminology | trial-use | 2 | brr | 2025-07 | hl7 | ncit |
| hl7.fhir.us.pq-cmc-fda | R5 | pqcmc-test-method-origin-terminology | Test Method Origin Terminology | trial-use | 2 | brr | 2025-07 | hl7 | ncit |
| hl7.fhir.us.pq-cmc-fda | R5 | pqcmc-test-usage-terminology | Test Usage Terminology | trial-use | 2 | brr | 2025-07 | hl7 | ncit |
| hl7.fhir.us.pq-cmc-fda | R5 | pqcmc-manufactured-dose-form-terminology | Manufactured Dose Form Terminology | trial-use | 2 | brr | 2025-07 | hl7 | ncit |
| hl7.fhir.us.pq-cmc-fda | R5 | pqcmc-units-of-measure | Units Of Measure | trial-use | 2 | brr | 2025-07 | hl7 | ucum |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.8004 | Test Results (Brucellosis) | active | 2020-01 | sct tho | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7976 | Test Titer Type (Brucellosis) | active | 2020-01 | sct tho | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7623 | Test Method (FDD) | active | 2020-01 | tho oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7917 | CPO PCR method (ARLN) | active | 2019-01 | sct oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7918 | CPO AST method (ARLN) | active | 2019-01 | sct oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7916 | CPO phenotypic method (ARLN) | active | 2019-01 | sct oid | |||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1032.319 | Steward Transfer Test | active | 2024-07 | hl7 | rx | ||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7626 | Test Result (FDD) | active | 2018-01 | sct tho oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.8039 | Test Results (Leptospirosis) | active | 2021-01 | sct tho | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7625 | Test Type (FDD) | active | 2020-01 | tho oid | |||
| signal.core.r4 | R4 | questionnaire-ccars-mental-health-services-program | Questionnaire CCARS Mental Health Services Program | draft | 1 | pa | hl7 | ||
| hl7.fhir.us.pq-cmc-fda | R5 | pqcmc-genc-and-iso-intersect | GENC and ISO 3166 Intersection | trial-use | 2 | brr | 2025-07 | hl7 | fhir |
| hl7.fhir.us.carin-bb | R4 | ADAUniversalNumberingSystem | American Dental Association Universal Numbering Value Set | trial-use | fm | 2025-02 | hl7 | tho | |
| fhir.argonaut.clinicalnotes | R3 | diagnosticreport-category | Argonaut DiagnosticReport Category Value Set | draft | 2018-05 | hl7 | loinc | ||
| fhir.argonaut.clinicalnotes | R3 | documentreference-category | Argonaut DocumentReferences Category Value Set | draft | 2018-05 | hl7 | internal | ||
| fhir.argonaut.clinicalnotes | R3 | argonaut-clinical-note-type | Argonaut DocumentReferences Type Value Set | draft | 2018-05 | hl7 | loinc | ||
| fhir.argonaut.scheduling | R3 | visit-type | Argonaut Visit Types | active | 2017-07 | hl7 | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.826 | Manufacturers of vaccines (MVX) | active | 2022-01 | tho | |||
| hl7.fhir.us.davinci-atr | R4 | atr-changetype | DaVinci ATR Change Types | trial-use | 2 | fm | 2020-09 | hl7 | fhir |
| hl7.fhir.us.davinci-atr | R4 | atr-attribution-list-status | DaVinci Attribution List Status | trial-use | 2 | fm | 2020-09 | hl7 | fhir |
| hl7.fhir.us.davinci-atr | R4 | davinci-group-characteristic | DaVinci Group Characteristic | trial-use | 2 | fm | 2020-09 | hl7 | fhir |
| hl7.fhir.us.carin-bb | R4 | FDANationalDrugCode | National Drug Code (NDC) Value Set | trial-use | fm | 2025-02 | hl7 | ndc | |
| hl7.fhir.us.davinci-pdex | R4 | FDANationalDrugCode | FDA National Drug Code (NDC) | informative | fm | 2025-06 | hl7 | ndc | |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7776 | Emergency Severity Index - Acuity | active | 2018-01 | oid | |||
| hl7.fhir.us.davinci-pct | R4 | PCTGFEItemNDCVS | PCT GFE Item NDC Value Set | trial-use | fm | 2025-08 | hl7 | ndc | |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.6039 | Funding Eligibility Observation Method (IIS) | active | 2012-01 | oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.113883.3.88.12.80.64 | Medication Fill Status Value Set | active | 2009-01 | tho | |||
| us.nlm.vsac | R4 | 2.16.840.1.113883.4.642.2.575 | Race Categories | active | 2025-04 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.4.642.40.2.48.3 | Ethnicity Categories | active | 2025-04 | hl7 | vsac | ||
| hl7.fhir.us.vitals | R4 | NumericResultIntNonPanicVS | Numeric Result Interpretation without panic values, value set | draft | 2024-10 | hl7 | tho | ||
| hl7.fhir.us.vitals | R4 | NumericResultIntVS | Numeric Result Interpretation value set | draft | 2024-10 | hl7 | tho | ||
| hl7.fhir.us.cardx-htn | R4 | NumericResultIntVS | Numeric Result Interpretation value set | draft | 2023-08 | hl7 | tho | ||
| us.cdc.phinvads | R4 | 2.16.840.1.113883.3.88.12.3221.3.2 | Contact Type Value Set | active | 2009-01 | tho | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.1066 | Healthcare Provider Taxonomy (HIPAA) | active | 2008-01 | tho | |||
| us.cdc.phinvads | R4 | 2.16.840.1.113883.11.19465 | Healthcare Provider Taxonomy Code (NUCC) | active | 2019-01 | nucc | |||
| hl7.fhir.us.covid19library | R4 | iso-state-codes-value-set | ISO Code System 3166 state/province codes. | active | 2022-07 | hl7 | iso | ||
| hl7.fhir.us.covid19library | R4 | iso-country-codes-value-set | ISO Code System 3166 country codes | active | 2022-07 | hl7 | iso | ||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7900 | Industry NAICS Detail (ODH) | active | 2020-01 | tho | |||
| hl7.fhir.us.cqfmeasures | R4 | intended-venue | Intended Venue | active | cqi | 2024-11 | hl7 | fhir |
FHIR